DRUG News and Press, Bright Minds Biosciences Inc. From 08/08/23

2023-08-08 12:46:20 ET Gainers: Infinity Pharmaceuticals ( INFI ) +56% . Bright Minds Biosciences ( DRUG ) +46% . Tilray Brands ( TLRY ) +31% . Paymentus Holdings (PAY) +33% . Gorilla Technology Group ( GRRR ) +28% . Cardiff Onco...

2023-08-08 10:21:19 ET Gainers: Bright Minds Biosciences ( DRUG ) +62% . Bionomics ( BNOX ) +24% . Novo Nordisk ( NVO ) +18% . Quanterix ( QTRX ) +17% . Tilray Brands ( TLRY ) +18% . Losers: Vistagen Therapeutics ( VTGN ...

-- BMB-101 is a highly selective and potent 5-HT 2C agonist being developed for the treatment of refractory epilepsies and other indications, such as psychosis, addiction, and impulse control disorders -- qEEG study was conducted in healthy individuals in Cohort 4 of the Multiple Ascend...

-- BMB-101 is a highly selective and potent 5-HT 2C agonist being developed for the treatment of refractory epilepsies and other indications, such as psychosis, addiction, and impulse control disorders -- BMB-101 demonstrated an excellent safety and tolerability profile in single ascendin...

Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences? PR Newswire NEW YORK , July 14, 2023 InvestorsObserver issues critical PriceWatch Alerts for MNMD, OPK, GRR, HYZN, and DRUG. ...

Toronto, Ontario--(Newsfile Corp. - Le 12 juillet/July 2023) - Bright Minds Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares. As a result, the outs...

2023-07-11 07:14:42 ET Bright Minds Biosciences ( NASDAQ: DRUG ) announces 5 to 1 common shares consolidation date to be on July 14,2023. The company had earlier announced its share consolidation intention to regain Nasdaq listing compliance. Source: Press Release ...

VANCOUVER, British Columbia, July 11, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatr...

2023-06-29 12:54:19 ET President Joe Biden is very "open-minded about" psychedelic medications, his youngest brother Frank Biden said during an interview on Wednesday, recalling a conversation the siblings had about the psychoactive substances. "He is very open-minded," the younger Bide...

2023-06-23 13:32:08 ET The U.S. Food and Drug Administration (FDA) published a new draft guidance on investigations into psychedelic drugs on Friday, detailing considerations for their clinical trials for the first time. The recommendations come at a time when there is growing public in...